ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-25 | 26-50 | 51-64

Results: 1-25/64

TREATMENT OF RELAPSING-REMITTING MULTIPLE -SCLEROSIS WITH COPOLYMER-1(GLATIRAMERACETATE)

Authors: DANG T GOEBELS N WALTHER EU HOHLFELD R

Citation: T. Dang et al., TREATMENT OF RELAPSING-REMITTING MULTIPLE -SCLEROSIS WITH COPOLYMER-1(GLATIRAMERACETATE), Aktuelle Neurologie, 25(4), 1998, pp. 159-164

ETIOLOGY AND PATHOGENESIS OF MYASTHENIA-GRAVIS

Authors: MELMS A HOHLFELD R

Citation: A. Melms et R. Hohlfeld, ETIOLOGY AND PATHOGENESIS OF MYASTHENIA-GRAVIS, Aktuelle Neurologie, 25, 1998, pp. 39-41

T-CELL HETEROGENEITY IN MUSCLE LESIONS OF INCLUSION-BODY MYOSITIS

Authors: BENDER A BEHRENS L ENGEL AG HOHLFELD R

Citation: A. Bender et al., T-CELL HETEROGENEITY IN MUSCLE LESIONS OF INCLUSION-BODY MYOSITIS, Journal of neuroimmunology, 84(1), 1998, pp. 86-91

PLACEBO-CONTROLLED MULTICENTER RANDOMIZED TRIAL OF INTERFERON BETA-1BIN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS

Authors: KAPPOS L POLMAN C POZZILLI C THOMPSON A DAHLKE F KNIGHT R HERN J COLEMAN R GERRIE L COOPER G MOORE J BORINGA J VANOOSTEN B RONNER H SCHRIJVER H TRUYEN L MONTALBAN J RIO J TINTORE M JACAS C MARZO E LECHNERSCOTT J HUBER S LIENERT C BRUNNSCHWEILER H HAWKINS S DROOGAN A MCDONNELL G DUDDY M MCKINSTRY S ALTENKIRCH H BAUM K EINHAUPL K MARX P POEWE W WALTER G AKMAN H BROCKMEIER B SCHERER P ZSCHENDERLEIN R SCHMIERER K GELDERBLOM H HARTMANN A STAPF C LUSCHOW A MACKERT B SCHUMACHER H MASUHR F HEMPEL T ZIMMERMANN R MUNCH M FRANCIS D HEAFIELD M ALMEMAR A WINER J CHONG M BROCHET B GAYOU A AURIACOMBE S DOUSSET V WILES C THOMAS F PICKERSGILL T HINDS N DAWSON K HUGHES T HUTCHINSON M MURPHY R REDMOND J WEBB S STOLL G JANDER S HAGEMANN G KOLLER H HANEMANN C KOLMEL H REICHEL D PETEREIT K THIEME A KHATAMI A NEUMANN M AMADUCCI L MASSACESI L SIRACUSA G AMATO M BARTOLOZZI L REPICE A MINDERHOUD J DEKEYSER J ZORGDRAGER A ZWANIKKEN C POSER S POLAK T GUNTHER A BITSCH A BORNER T WEBER F WIKSTROM J FARKKILA M MAJURI H SUMELAHTI M TELAKIVI T FREDRIKSON S MARTIN C MILLER D ORIORDAN J BREX P KAPOOR R WERRING D CONFAVREUX C BRUNET P HANNOUN D BRUDON F MOREAU T BLANC S DHOOGHE M JACOBS K LISSOIR F DEMONTY L COMI G COLOMBO B ROSSI P RODEGHER M SANTUCCIO G MARTINELLI F HOHLFELD R WALTHER E GOEBELS N DANG T LINDERT R VOLTZ R CARTLIDGE N BATES D MORAN G PANDIT L WESTWOOD M HALLER P SOMMER J BITTER J SUSS F MELLIES J MUCHA P LYONCAEN O DEGOS JD ROULLET E LUBETZKI C CREANGE A TOURBAH A PEZ D LECANUET P NICOLT P EDAN G BELLIARD S DEMARCO O CAHAGNE V DEBURGHGRAEVE V BRUNET I FIESCHI C MILLEFIORINI E GASPERINI C BUTTINELLI C FRONTINI M HOWELL S HADJIVASSILIOU M GIBSON A GRAHAM A HARKNESS K LAWDEN M CLANET M WAUBAN E AZAISVUILLEMIN C LAU G LOUIS C PANELIUS M RUUTIAINEN J ERALINNA J SOILUHANNINEN M GOLD R HARTUNG HP JUNG S BAYAS A FLACHENECKER P WEILBACH F ARCHELOS J KOLLEGGER H VASS K ASENBAUM S CHATSAKOS T BECKMANN K GHAZI M WAGNER K MILTENBURGER C MCFARLAND H PETKAU J SABOURAUD O TOYKA K

Citation: L. Kappos et al., PLACEBO-CONTROLLED MULTICENTER RANDOMIZED TRIAL OF INTERFERON BETA-1BIN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS, Lancet, 352(9139), 1998, pp. 1491-1497

THE HUMAN ANTI-T CELL-RECEPTOR REPERTOIRE - IMPLICATIONS FOR VACCINATION THERAPY OF MULTIPLE-SCLEROSIS (MS)

Authors: ZIPP F KERSCHENSTEINER M DORNMAIR K GIEGERICH G WEKERLE H HOHLFELD R

Citation: F. Zipp et al., THE HUMAN ANTI-T CELL-RECEPTOR REPERTOIRE - IMPLICATIONS FOR VACCINATION THERAPY OF MULTIPLE-SCLEROSIS (MS), Neurology, 50(4), 1998, pp. 54004-54004

LONG-TERM DEVELOPMENT OF THE HUMAN MBP SPECIFIC T-CELL REPERTOIRE - EPITOPE SPREADING VERSUS CLONAL PERSISTENCE

Authors: GOEBELS N SCHMIDT H BRUNNER C HOFSTETTER H SOLCH M WEKERLE H HOHLFELD R

Citation: N. Goebels et al., LONG-TERM DEVELOPMENT OF THE HUMAN MBP SPECIFIC T-CELL REPERTOIRE - EPITOPE SPREADING VERSUS CLONAL PERSISTENCE, Neurology, 50(4), 1998, pp. 54005-54005

CHARACTERIZATION OF MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-SPECIFIC T-CELL LINES FROM MULTIPLE-SCLEROSIS PATIENTS AND HEALTHY DONORS

Authors: LINDERT RB LININGTON C WEKERLE H HOHLFELD R

Citation: Rb. Lindert et al., CHARACTERIZATION OF MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-SPECIFIC T-CELL LINES FROM MULTIPLE-SCLEROSIS PATIENTS AND HEALTHY DONORS, Neurology, 50(4), 1998, pp. 54007-54007

HUMAN MUSCLE-CELLS EXPRESS A FUNCTIONAL COSTIMULATORY MOLECULE DISTINCT FROM B7,1 (CD80) AND B7,2 (CD86) IN-VITRO AND IN INFLAMMATORY LESIONS

Authors: BEHRENS L KERSCHENSTEINER M MISGELD T GOEBELS N WEKERLE H HOHLFELD R

Citation: L. Behrens et al., HUMAN MUSCLE-CELLS EXPRESS A FUNCTIONAL COSTIMULATORY MOLECULE DISTINCT FROM B7,1 (CD80) AND B7,2 (CD86) IN-VITRO AND IN INFLAMMATORY LESIONS, The Journal of immunology (1950), 161(11), 1998, pp. 5943-5951

DIVERSITY OF THE ANTI-T-CELL RECEPTOR IMMUNE-RESPONSE AND ITS IMPLICATIONS FOR T-CELL VACCINATION THERAPY OF MULTIPLE-SCLEROSIS

Authors: ZIPP F KERSCHENSTEINER M DORNMAIR K MALOTKA J SCHMIDT S BENDER A GIEGERICH G MALEFYT RD WEKERLE H HOHLFELD R

Citation: F. Zipp et al., DIVERSITY OF THE ANTI-T-CELL RECEPTOR IMMUNE-RESPONSE AND ITS IMPLICATIONS FOR T-CELL VACCINATION THERAPY OF MULTIPLE-SCLEROSIS, Brain (Print), 121, 1998, pp. 1395-1407

RANDOMIZED TRIAL OF PLASMA-EXCHANGE, INTRAVENOUS IMMUNOGLOBULIN, AND COMBINED TREATMENTS IN GUILLAIN-BARRE-SYNDROME

Authors: HUGHES RAC SWAN AV CORNBLATH DR HARTUNG HP BRIL V FEASBY T HAHN A ROPPER A STECK A TOYKA KV VALLAT JM NEWSOMDAVIS J BUTTON S HOHLFELD R VOLTZ R LECKY BRF WINER JB REES J DONAGHY M DEHAENE I MARCHAU M VANZANDIJCKE M HOOGHE MD HACKE W NEWMAN PK SHAKIR R TILLEY P KHATRI B KUMAR J SUNDRANI S WILLISON H KATIFI H WILES CM HAMANN G MERKELBACH S STEWART J LUIS MLS ALVES M CONCEICAO I PYE IF ROBBERECHT W PEETERS E AASLY J FUHR P TICHELLI A SINDIC C VANDENBURGH P FRANCK F DIVE D CAVALETTI G SANTORO P FEASBY TE MILLER DH HOWARD RS ORIORDAN J CHALK C BENHUR T GOLDSTEIN JM VANORSHOVEN M CAEKEBEKE J SCHMEDDING E FERGUSON IT STOLL G WILL RG POLLARD J

Citation: Rac. Hughes et al., RANDOMIZED TRIAL OF PLASMA-EXCHANGE, INTRAVENOUS IMMUNOGLOBULIN, AND COMBINED TREATMENTS IN GUILLAIN-BARRE-SYNDROME, Lancet, 349(9047), 1997, pp. 225-230

GROWTH TRANSFORMATION OF ANTIGEN-SPECIFIC T-CELL LINES FROM RHESUS-MONKEYS BY HERPESVIRUS-SAIMIRI

Authors: MEINL E FICKENSCHER H HOCH RM MALEFYT RD HART BAT WEKERLE H HOHLFELD R FLECKENSTEIN B

Citation: E. Meinl et al., GROWTH TRANSFORMATION OF ANTIGEN-SPECIFIC T-CELL LINES FROM RHESUS-MONKEYS BY HERPESVIRUS-SAIMIRI, Virology, 229(1), 1997, pp. 175-182

PARANEOPLASTIC MYASTHENIA-GRAVIS - DETECTION OF ANTI-MGT30 (TITIN) ANTIBODIES PREDICTS THYMIC EPITHELIAL TUMOR

Authors: VOLTZ RD ALBRICH WC NAGELE A SCHUMM F WICK M FREIBURG A GAUTEL M THALER HT AARLI J KIRCHNER T HOHLFELD R

Citation: Rd. Voltz et al., PARANEOPLASTIC MYASTHENIA-GRAVIS - DETECTION OF ANTI-MGT30 (TITIN) ANTIBODIES PREDICTS THYMIC EPITHELIAL TUMOR, Neurology, 49(5), 1997, pp. 1454-1457

PARANEOPLASTIC MYASTHENIA-GRAVIS - COMPARISON OF ANTI-MGT30 ELISA ANDANTI-STRIATIONAL IMMUNOFLUORESCENCE ASSAY FOR DETECTION OF THYMIC EPITHELIAL TUMOR

Authors: VOLTZ RD ALBRICH WC NAEGELE A SCHUMM F WICK M GAUTEL M AARLI J KIRCHNER T HOHLFELD R

Citation: Rd. Voltz et al., PARANEOPLASTIC MYASTHENIA-GRAVIS - COMPARISON OF ANTI-MGT30 ELISA ANDANTI-STRIATIONAL IMMUNOFLUORESCENCE ASSAY FOR DETECTION OF THYMIC EPITHELIAL TUMOR, Neurology, 48(3), 1997, pp. 1004-1004

PARANEOPLASTIC MYASTHENIA-GRAVIS - CORRELATION OF ANTI-MGT30 ANTIBODIES AND THYMIC EPITHELIAL TUMOR HISTOLOGY

Authors: ALBRICH WC KIRCHNER T SOMMER N WICK M GAUTEL M AARLI J HOHLFELD R VOLTZ RD

Citation: Wc. Albrich et al., PARANEOPLASTIC MYASTHENIA-GRAVIS - CORRELATION OF ANTI-MGT30 ANTIBODIES AND THYMIC EPITHELIAL TUMOR HISTOLOGY, Neurology, 48(3), 1997, pp. 1127-1127

FORMATION OF NEUTRALIZING ANTIBODIES DURI NG THERAPY OF MULTIPLE-SCLEROSIS WITH INTERFERON BETA-1B - PRACTICAL PROCEDURE WHEN TREATMENT FAILURE IS SUSPECTED

Authors: WALTHER EU DANG T HARTUNG HP HOHLFELD R

Citation: Eu. Walther et al., FORMATION OF NEUTRALIZING ANTIBODIES DURI NG THERAPY OF MULTIPLE-SCLEROSIS WITH INTERFERON BETA-1B - PRACTICAL PROCEDURE WHEN TREATMENT FAILURE IS SUSPECTED, Nervenarzt, 68(12), 1997, pp. 935-939

MULTIPLE-SCLEROSIS - LONGITUDINAL MEASUREMENT OF INTERLEUKIN-1 RECEPTOR ANTAGONIST

Authors: VOLTZ R HARTMANN M SPULER S SCHELLER A MAI N HOHLFELD R YOUSRY T

Citation: R. Voltz et al., MULTIPLE-SCLEROSIS - LONGITUDINAL MEASUREMENT OF INTERLEUKIN-1 RECEPTOR ANTAGONIST, Journal of Neurology, Neurosurgery and Psychiatry, 62(2), 1997, pp. 200-201

MULTIPLE-SCLEROSIS - COMPARISON OF THE HUMAN T-CELL RESPONSE TO S100-BETA AND MYELIN BASIC-PROTEIN REVEALS PARALLELS TO RAT EXPERIMENTAL AUTOIMMUNE PANENCEPHALITIS

Authors: SCHMIDT S LININGTON C ZIPP F SOTGIU S MALEFYT RD WEKERLE H HOHLFELD R

Citation: S. Schmidt et al., MULTIPLE-SCLEROSIS - COMPARISON OF THE HUMAN T-CELL RESPONSE TO S100-BETA AND MYELIN BASIC-PROTEIN REVEALS PARALLELS TO RAT EXPERIMENTAL AUTOIMMUNE PANENCEPHALITIS, Brain, 120, 1997, pp. 1437-1445

CYTOTOXIC MECHANISMS IN INFLAMMATORY MYOPATHIES - COEXPRESSION OF FASAND PROTECTIVE BCL-2 IN MUSCLE-FIBERS AND INFLAMMATORY CELLS

Authors: BEHRENS L BENDER A JOHNSON MA HOHLFELD R

Citation: L. Behrens et al., CYTOTOXIC MECHANISMS IN INFLAMMATORY MYOPATHIES - COEXPRESSION OF FASAND PROTECTIVE BCL-2 IN MUSCLE-FIBERS AND INFLAMMATORY CELLS, Brain, 120, 1997, pp. 929-938

BIOTECHNOLOGICAL AGENTS FOR THE IMMUNOTHERAPY OF MULTIPLE-SCLEROSIS -PRINCIPLES, PROBLEMS AND PERSPECTIVES

Authors: HOHLFELD R

Citation: R. Hohlfeld, BIOTECHNOLOGICAL AGENTS FOR THE IMMUNOTHERAPY OF MULTIPLE-SCLEROSIS -PRINCIPLES, PROBLEMS AND PERSPECTIVES, Brain, 120, 1997, pp. 865-916

ENCEPHALITOGENIC POTENTIAL OF MYELIN BASIC PROTEIN-SPECIFIC T-CELLS ISOLATED FROM NORMAL RHESUS MACAQUES

Authors: MEINL E HOCH RM DORNMAIR K MALEFYT RD BONTROP RE JONKER M LASSMANN H HOHLFELD R WEKERLE H THART BA

Citation: E. Meinl et al., ENCEPHALITOGENIC POTENTIAL OF MYELIN BASIC PROTEIN-SPECIFIC T-CELLS ISOLATED FROM NORMAL RHESUS MACAQUES, The American journal of pathology, 150(2), 1997, pp. 445-453

THE USE OF INTRAVENOUS IMMUNOGLOBULINS IN THE TREATMENT OF NEUROMUSCULAR DISORDERS

Authors: VOLTZ R HOHLFELD R

Citation: R. Voltz et R. Hohlfeld, THE USE OF INTRAVENOUS IMMUNOGLOBULINS IN THE TREATMENT OF NEUROMUSCULAR DISORDERS, Current opinion in neurology, 9(5), 1996, pp. 360-366

CURRENT IMMUNOTHERAPY OF MULTIPLE-SCLEROSIS - A REVIEW OF CLINICAL-EXPERIENCE

Authors: MARTIN R HOHLFELD R

Citation: R. Martin et R. Hohlfeld, CURRENT IMMUNOTHERAPY OF MULTIPLE-SCLEROSIS - A REVIEW OF CLINICAL-EXPERIENCE, CLINICAL IMMUNOTHERAPEUTICS, 5, 1996, pp. 12-21

INTERFERON BETA-1B IN MULTIPLE-SCLEROSIS - A SEMINAR-IN-PRINT - QUESTIONS AND ANSWERS

Authors: THOMPSON AJ HOHLFELD R TYRING SK REDER AT SIBLEY WA LI DKB

Citation: Aj. Thompson et al., INTERFERON BETA-1B IN MULTIPLE-SCLEROSIS - A SEMINAR-IN-PRINT - QUESTIONS AND ANSWERS, CLINICAL IMMUNOTHERAPEUTICS, 5, 1996, pp. 55-58

IMMUNOPATHOGENESIS OF MYOSITIS

Authors: HOHLFELD R

Citation: R. Hohlfeld, IMMUNOPATHOGENESIS OF MYOSITIS, Nervenheilkunde, 15(1), 1996, pp. 1-3

MULTIPLE-SCLEROSIS - PROSPECTIVE ANALYSIS OF TNF-ALPHA AND 55 KDA TNFRECEPTOR IN CSF AND SERUM IN CORRELATION WITH CLINICAL AND MRI ACTIVITY

Authors: SPULER S YOUSRY T SCHELLER A VOLTZ R HOLLER E HARTMANN M WICK M HOHLFELD R

Citation: S. Spuler et al., MULTIPLE-SCLEROSIS - PROSPECTIVE ANALYSIS OF TNF-ALPHA AND 55 KDA TNFRECEPTOR IN CSF AND SERUM IN CORRELATION WITH CLINICAL AND MRI ACTIVITY, Journal of neuroimmunology, 66(1-2), 1996, pp. 57-64

Risultati: 1-25 | 26-50 | 51-64